Reply To: FDA Guideline for Data Integrity

December 9, 2024 at 12:17 am #6575
Pharma Digests
Pharma Expert

    Most common DI issues in Pharma:
    1. Backdating of Postdating
    2. Difference between raw data and recoded data
    3. Data hidden
    4. Inconsistencies in Data
    5. Access by Unauthorized Individuals etc.